Nov 8, 2013
Just Released: "Sigma-Tau Pharmaceuticals, Inc. - Pharmaceuticals &...
Sigma-Tau Pharmaceuticals, Inc. is a research based biotechnology company that focuses on discovering and developing novel medicines to treat rare diseases.
Wed Aug 28, 2013
Hodgkin Lymphoma Treatment Tied to Higher Risk of Stomach Cancer in Study
Hodgkin lymphoma is a cancer of the immune system and is one of the most common cancers among teens and young adults in the United States.
Tue Jul 09, 2013
Hypersensitivity reactions to anticancer agents: data mining of the...
Journal of experimental & clinical cancer research : CR , Vol. 30, No. 1. , doi:10.1186/1756-9966-30-93 Previously, adverse event reports submitted to the US Food and Drug Administration database were reviewed to confirm platinum agent-associated hypersensitivity reactions.
Fri Jun 21, 2013
Sigma-Tau Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare -...
It product portfolio comprises prescription products and consumer products. Sigma-Tau's prescription products include Adagen , Matulane , Carnitor , Oncaspar , Depocyt and Abelcet .
Fri May 31, 2013
Patients With Anaplastic Oligodendroglioma Identified Who May Benefit From Adjuvant PCV
A further report on the results of EORTC trial 26951 indicates that CpG island methylator phenotype status and O 6-methylguanine-DNA methyltransferase promoter methylation as assessed by MGMT-STP27 are the most informative for identifying grade III glioma patients who might benefit from the addition of procarbazine, CCNU and vincristine ... (more)